Duche J C, Barre J, Guinot P, Duchier J, Cournot A, Tillement J P
Laboratoire Hospitalo-Universitaire de Pharmacologie, Centre Hospitalier Intercommunal, Creteil, France.
Int J Clin Pharmacol Res. 1989;9(3):165-8.
Twenty-four healthy volunteers were divided in three groups who were randomly assigned different treatments for 13 days: group I received 400 mg/day of a defined Ginkgo biloba extract (GBE), group II 300 mg/day of phenytoin and group III a placebo. The elimination half-life of antipyrine was measured with a high performance liquid chromatographic technique initially and on the last day of the administration of the treatments. The results show that the half-life of antipyrine was not affected by GBE and placebo treatments, whereas it was significantly decreased (p less than 0.05) frm 12.2 to 6.8 h after phenytoin control treatment. This study demonstrates that GBE has no effect on the hepatic microsomal drug oxidation system.
24名健康志愿者被分为三组,随机接受不同治疗,为期13天:第一组每天服用400毫克特定的银杏叶提取物(GBE),第二组每天服用300毫克苯妥英钠,第三组服用安慰剂。最初以及在治疗给药的最后一天,采用高效液相色谱技术测定安替比林的消除半衰期。结果显示,GBE和安慰剂治疗对安替比林的半衰期没有影响,而在苯妥英钠对照治疗后,安替比林的半衰期从12.2小时显著缩短至6.8小时(p小于0.05)。本研究表明,GBE对肝微粒体药物氧化系统没有影响。